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mission Errors’ had a correlation coeffi-
cient of –0.46 with morphine exposure
(p = 0.05), i.e. a higher exposure to mor-
phine was associated with a lower number 
of errors. The other significant correlation 
of –0.46 indicates that children with mor-
phine exposure performed worse on the 
subtest ‘Recognition’. So, out of 15 NEPSY 
test scores, higher morphine exposure was 
associated with a worse performance in 
only 1 test score. Interestingly, none of the 
15 test scores was significantly correlated to 
gestational age or number of painful proce-
dures. The most important findings with 
regard to these children’s neuropsycholog-
ical functioning are that overall they scored 
‘average’ and that there were no statistical-
ly significant differences in neuropsycho-
logical functioning between the case sub-
jects and healthy controls.
 Indeed, only 11 out of 19 children suc-
cessfully completed MRI scanning. Chil-
dren were excluded not only because of 
poor image quality, but also because of 
MRI contraindications (e.g. placement of a 
clip in cardiac surgery). The mean cumula-
tive dose of morphine given in the first 28 
days of life was 973 μg/kg (SD 1,447) in 
those 11 children versus 886 (SD 1,268) in 
 Dear Sir, 
 We thank Holsti and colleagues for 
their comments on our findings. Indeed, as 
they summarized, we found significant 
correlations (range 0.60–0.85) between 
specific brain volumes and important clin-
ical variables such as gestational age, num-
ber of painful procedures and morphine 
exposure. However, there were no signifi-
cant correlations between these variables 
and brain functioning as reflected by ther-
mal sensitivity. Likewise, we found no dif-
ferences between case subjects and healthy 
controls with respect to detection and pain 
thresholds. We were specifically interested 
in thermal sensitivity and neuropsycholog-
ical functioning, as in several animal stud-
ies pain sensitivity and cognition were neg-
atively associated with neonatal pain and 
opioid exposure.
 Neuropsychological outcome was in-
deed moderately but significantly correlat-
ed with morphine exposure, as reflected by 
2 out of the 15 NEPSY test scores: number 
of ‘Commission Errors’ in the subtest ‘Re-
sponse Set’ and total score for ‘Recognition’ 
in the subtest ‘Narrative Memory’. How-
ever, the direction of one of these correla-
tions was different from how Holsti and 
colleagues interpret this. Number of ‘Com-
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the 8 excluded children (nonsignificant:
p = 0.89). Three of the 11 children included 
in the MRI analyses did not receive mor-
phine in the first 4 weeks of life. In  table 1 , 
we present all the raw data on the brain vol-
umes per child included in the MRI analy-
ses as well as the distribution of morphine 
exposure. Since many children are referred 
to a peripheral hospital after weeks of care 
in an academic hospital, we present only 
the morphine exposure in the first 28 days 
of life to circumvent bias due to missing 
data. Moreover, it is thought that neonatal 
pain and opioid exposure in the first weeks 
of life would have the most detrimental ef-
fects in the long term since the brain is rap-
idly developing in this period.
 We presented a sample of preterm 
children in a range reflecting the clinical 
situation rather than including only chil-
dren born extremely preterm or born with 
an extremely low birth weight. In addi-
tion, 10 μg/kg/h is not a low dose in Eu-
rope, but was the standard prescribed dos-
age at the time of our study. Based on pre-
vious pharmacokinetic and pharmacody-
namic studies, we have even started to use 
lower doses in, for example, postoperative 
care  [1, 2] .
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 We believe that prematurity, opioid ex-
posure and neonatal pain may have impor-
tant consequences for brain morphology, 
and the crucial issue in this regard is 
whether only the brain structures are af-
fected or brain function as well? Based on 
our findings, we would like to see the glass 
half full rather than half empty; in this 
small group of children born preterm with 
a history of NICU admission, brain mor-
phology was negatively correlated to pre-
maturity, opioid exposure and neonatal 
pain, whereas brain function was not, sug-
gesting that there are no major clinically 
relevant effects of prematurity, opioid ex-
posure and neonatal pain. Larger studies 
are needed of course to confirm our find-
ings.
 
 Table 1.  Global brain volumes and volumes of pain-related brain regions per case (n = 11 cases)
Morphine,
μg/kg
Brain volumes, cm3
total brain
volume
cerebral
WM
total 
gray
volume
parietal
lobe
frontal 
lobe
cerebellum
WM
cerebellum
cortex
thalamus amygdala ACC insula
left right left right left right left right left right left right left right le ft right
0 1,129 370 697 71 70 96 97 15 14 61 60 7.7 7.2 1.6 1.8 1.8 2.9 7.6 7.1
0 1,176 406 739 75 74 107 108 12 12 53 53 6.6 7.0 1.9 1.8 1.4 2.9 8.1 8.3
0 1,200 396 756 76 78 112 109 15 16 64 66 7.0 7.1 1.5 1.7 2.2 2.9 5.9 6.1
135 1,177 395 733 72 74 113 109 14 13 57 56 6.1 5.8 1.9 1.8 2.0 3.3 6.5 6.7
240 1,299 424 818 89 85 121 121 15 15 60 60 6.8 7.0 1.8 1.8 1.9 2.9 7.4 6.9
394 1,238 411 760 81 86 108 100 14 16 54 56 7.5 7.4 1.1 1.3 1.9 2.2 7.7 7.7
714 1,094 364 696 69 73 104 104 10 11 53 52 6.0 6.4 1.4 1.4 2.7 2.1 7.1 6.8
993 1,150 364 750 71 80 109 107 13 12 59 61 7.0 8.0 1.6 1.6 1.9 3.2 6.7 6.6
1,320 1,045 340 669 65 68 97 102 11 11 55 56 6.7 5.8 1.7 1.7 2.3 1.8 6.3 6.4
2,030 1,011 334 644 67 64 99 89 12 12 58 61 6.1 5.6 1.6 1.5 2.2 2.5 7.1 6.4
4,873 904 284 587 60 62 89 85 10 11 44 46 4.8 5.3 1.4 1.4 1.8 2.6 6.1 5.5
 WM = White matter. ACC = anterior cingulate cortex.
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